文献速递类风湿关节炎

1990至2021年全球、区域及国家类风湿关节炎流行病学趋势:基于2021年全球疾病负担研究的年龄-时期-队列效应分析

Global, regional and national trends in the epidemiology of rheumatoid arthritis from 1990 to 2021: an age-period-cohort effect analysis of the global burden of disease study 2021.
PubMed 文献 · RMD Open · 2025-04-12

本研究基于2021年全球疾病负担研究数据,分析1990至2021年全球、区域及国家类风湿关节炎的发病率、患病率和死亡率趋势,并采用年龄-时期-队列模型估计净漂移、局部漂移及年龄/时期/队列相对风险。全球年龄标化发病率和患病率上升而死亡率下降;低-中社会人口指数地区发病和患病增幅最显著,高社会人口指数地区死亡率降幅最大;爱尔兰2021年年龄标化发病率和患病率最高,洪都拉斯年龄标化死亡率最高;年龄效应在发病65-69岁、患病80-84岁达峰,死亡风险随年龄增加;较年轻出生队列发病和患病风险增加而死亡风险降低。

要点

  • 1990至2021年全球类风湿关节炎年龄标化发病率和患病率上升,年龄标化死亡率下降。
  • 低-中社会人口指数地区发病和患病增幅最显著,高社会人口指数地区死亡率降幅最大。
  • 年龄效应在发病65-69岁、患病80-84岁达峰,死亡风险随年龄增加。

核心结论

  • 全球类风湿关节炎发病率和患病率上升,而死亡率下降;区域、人口学和时间差异凸显需针对性公共卫生策略以应对日益增长的负担。

研究设计与样本

  • 从2021年全球疾病负担研究中提取类风湿关节炎年龄标化发病率、患病率和死亡率(每10万人口),采用年龄-时期-队列模型估计净漂移、局部漂移及年龄/时期/队列相对风险。

主要发现

  • 全球1990至2021年年龄标化发病率(ASIR)和年龄标化患病率(ASPR)上升,年龄标化死亡率(ASMR)下降。
  • 低-中社会人口指数(SDI)地区发病和患病增幅最显著,高SDI地区类风湿关节炎死亡率降幅最大。
  • 东南亚区域发病和患病增幅最显著,非洲区域死亡率降幅最大。
  • 2021年爱尔兰报告的ASIR和ASPR最高,洪都拉斯共和国报告的ASMR最高。
  • 年龄效应在发病65-69岁、患病80-84岁达峰,死亡风险随年龄增加;时期效应显示发病和患病上升但死亡率下降,较年轻出生队列发病和患病风险增加而死亡风险降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rheumatoid arthritis (RA) poses a significant global health challenge. This study examined trends in the incidence, prevalence and mortality of RA from 1990 to 2021 at global, regional and national levels, alongside age, period and cohort effects. METHODS: Age-standardised rates (per 100 000 population) on RA incidence, prevalence and mortality were extracted from the Global Burden of Disease (GBD) study 2021. An age-period-cohort model estimated the overall annual percentage change (net drift), annual percentage change within each age group (local drift), and age/period/cohort relative risks. RESULTS: Globally, from 1990 to 2021, the age-standardised incidence rate (ASIR) and the age-standardised prevalence rate (ASPR) of RA increased; while age-standardised mortality rate (ASMR) decreased. Low-middle sociodemographic index (SDI) region showed the most notable increases in incidence and prevalence, while high SDI region had the largest decline in RA mortality. The South-East Asia Region exhibited the most significant increases in incidence and prevalence, and the African Region had the greatest mortality decline. Ireland reported the highest ASIR and ASPR in 2021, while the Republic of Honduras had the highest ASMR. Age effects peaked at 65-69 years for incidence and 80-84 years for prevalence, with the mortality risk increased with age. Period effects indicated rising incidence and prevalence but declining mortality, while younger birth cohorts showed increasing risks of incidence and prevalence and decreasing mortality risk. CONCLUSION: RA incidence and prevalence have risen globally, while mortality has declined. The regional, demographic and temporal variations underscore the need for targeted public health strategies to address the growing burden.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tang K, Zhu L, Shan S, et al. Global, regional and national trends in the epidemiology of rheumatoid arthritis from 1990 to 2021: an age-period-cohort effect analysis of the global burden of disease study 2021. RMD Open. 2025. PMID: 40221149. doi:10.1136/rmdopen-2024-005383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。